Discussions about heart health often center around blood pressure and cholesterol, with factors like poor sleep, smoking, family history of heart disease, and chronic stress thrown in. However, ...

A novel type of therapy, known as ANGPTL3 inhibitor therapy, was effective in lowering triglycerides in certain types of patients with severe hypertriglyceridemia (sHTG) who had a prior episode(s) of ...

ATLANTA, GA—Investigational agents that work by inhibiting apolipoprotein C-III (APOC3) are effective at reducing triglyceride levels, two phase IIb studies show. In Bridge-TIMI 73a, treatment with ...

The evidence for elevated triglycerides, as a cardiac risk factor, is nowhere near as well understood as the risk from high LDL and low HDL cholesterol. However, the growing body of epidemiologic ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented final data from the double-blind treatment period of its Phase 2 SHASTA-2 study of investigational ...

Clin Lipidology. 2009;4(4):425-437. Clinical event trials are urgently needed to assess treatment strategies for dyslipidemia management, including POM3 treatment, in patients with ...

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that causes very high triglyceride levels in the body. Tryngolza (olezarsen) was approved in 2024 and is the first and only ...

HANGZHOU, China, Sept. 30, 2024 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases ...

Credit: Ionis Tryngolza is an apoC-III-directed antisense oligonucleotide that is administered subcutaneously once monthly. As an adjunct to a low fat diet, Tryngolza significantly reduced fasting ...

The Global "Hypertriglyceridemia Treatment Market" Informational Report provides an in-depth examination of market dynamics to help businesses make strategic decisions. It facilitates trend ...

—A recent study highlights the importance of differentiating familial chylomicronemia syndrome (FCS) from multifactorial chylomicronemia syndrome (MCS) for setting expectations, guiding genetic ...

DEAR DR. ROACH: About 10 years ago, after a blood test, my doctor noted that my triglycerides were about 450, whereas the norm would be below 150. He didn’t seem alarmed, so for the next two years I ...